Infusion of Apomorphine: Long-term Safety Study (NCT02339064)
A Phase 3, Open-Label Study of the Safety, Efficacy and Tolerability of Apomorphine Administered by Continuous Subcutaneous Infusion in Advanced Parkinson's Disease Patients With Unsatisfactory Control on Available Therapy
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 3, multicenter, open-label, safety and tolerability study of continuous apomorphine infusion in subjects with advanced Parkinson's Disease (PD) whose motor fluctuations remain unsatisfactory with levodopa (or levodopa/carbidopa) and at least one other class of drugs or mode of therapy for PD.
Who can join: Review the eligibility criteria below.
Location: Clinical Research Facility — Phoenix, Arizona
Age range: 30 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Clinical Research Facility — Phoenix, Arizona
- Clinical Research Facility — Loma Linda, California
- Clinical Research Facility — Los Angeles, California
- Clinical Research Facility — Los Angeles, California
- Clinical Research Facility — Aurora, Colorado
- Clinical Research Facility — Englewood, Colorado
- Clinical Research Facility — Boca Raton, Florida
- Clinical Research Facility — Atlanta, Georgia
- Clinical Research Facility — Augusta, Georgia
- Clinical Research Facility — Chicago, Illinois
- Clinical Research Facility — Chicago, Illinois
- Clinical Research Facility — Kansas City, Kansas
- Clinical Research Facility — West Bloomfield, Michigan
- Clinical Research Facility — Albany, New York
- Clinical Research Facility — Cincinnati, Ohio
- Portland VA Medical Center — Portland, Oregon
- Clinical Research Facility — Philadelphia, Pennsylvania
- Clinical Research Facility — Kirkland, Washington
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Idiopathic Parkinson's Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.